BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33599914)

  • 21. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
    Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
    J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
    Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
    Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.
    Lee WP; Shetty SS; Seah CMJ; Tan PT; Tan SM
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1646. PubMed ID: 35892151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 27. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study.
    Guan X; Xu G; Shi A; Zou Y; Zhan Y; Fan Z; Dong Y
    Medicine (Baltimore); 2020 Dec; 99(50):e23487. PubMed ID: 33327281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
    Venkatesh SL; Oseni TO; Bahl M
    Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
    Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
    Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.
    Sheaffer WW; Gray RJ; Wasif N; Stucky CC; Cronin PA; Kosiorek HE; Basu A; Pizzitola VJ; Patel B; Giurescu ME; Lorans R; McCullough AE; Ocal IT; Pockaj BA
    Am J Surg; 2019 Jun; 217(6):1025-1029. PubMed ID: 30879795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?
    Ouldamer L; Lechaux E; Arbion F; Body G; Vildé A
    Breast; 2014 Dec; 23(6):889-93. PubMed ID: 25456102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
    Wong H; Lau S; Leung R; Chiu J; Cheung P; Wong TT; Liang R; Epstein RJ; Yau T
    Med Oncol; 2012 Sep; 29(3):1536-42. PubMed ID: 21983862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component.
    Zeng Y; Gao W; Chen X; Shen K
    Br J Cancer; 2021 Mar; 124(5):975-981. PubMed ID: 33335279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precise application of sentinel lymph node biopsy in patients with ductal carcinoma in situ: A systematic review and meta-analysis of real-world data.
    Chiu CW; Chang LC; Su CM; Shih SL; Tam KW
    Surg Oncol; 2022 Dec; 45():101880. PubMed ID: 36332555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
    Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.